Public health experts cite concerns about the increased incidence of a rare but potentially serious blood clotting condition among those who received the company’s shot.Public health experts cite concerns about the increased incidence of a rare but potentially serious blood clotting condition among those who received the company’s shot.Blood Clots, Vaccination and Immunization, Coronavirus (2019-nCoV), Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, Food and Drug Administration, Johnson & JohnsonRead More
